Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: SHOX2 cooperates with STAT3 to promote breast cancer metastasis through the transcriptional activation of WASF3

Fig. 1

SHOX2 in TCGA breast cancer patient samples. (a) Higher SHOX2 expression corresponds with significantly worse progression free survival and disease-specific survival. (b) SHOX2 expression is differentially overexpressed in estrogen receptor-negative (ER) breast tumors when compared to estrogen receptor-positive (ER+) tumors. **** p < 0.0001. (c, d) Breast tumors deemed “SHOX2-high” tumors (z-score > 1.25) differentially overexpressed transcripts preferentially involved in the epithelial-to-mesenchymal transitioning. (e) SHOX2 expression significantly correlates with the MSigDB Gene Hallmark dataset “EPITHELIAL_MESENCHYMAL_TRANSITION”

Back to article page